Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$115.3K
228.00 shares
What this filing means
MESA NILDA plans to sell 228.00 shares of UNITED THERAPEUTICS CORP valued at approximately $115.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/14/2026ACC: 0001950047-26-009414
228.00
Shares to sell
$115.3K
Approx. market value
228.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
9/14/2026
130.00Restricted Stock
Not Applicable
7/9/2026
98.00Total acquired228.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/14/2026 | Stock Option Exercise Cash | 130.00 | — |
7/9/2026 | Restricted Stock Not Applicable | 98.00 | — |
| Total | 228.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
228.00
Market value
$115.3K
9/14/2026
Total
Units
228.00
Value
$115.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/14/2026 | 228.00 | $115.3K | NASDAQ | Planned |
| Total | 228.00 | $115.3K | ||